Latest News
GSK wins speedy FDA Zejula review in ovarian cancer niche
GlaxoSmithKline has been working to restrengthen in cancer, particularly through a multibillion-dollar purchase of Tesaro. The main drug from the buyout, Zejula, is now...
PatientsLikeMe acquired by UnitedHealth Group
UnitedHealth Group has acquired Cambridge, Massachusetts-based patient social networking site PatientsLikeMe a few months after regulators forced its major Chinese investor iCarbonX to divest from...
More
GSK wins speedy FDA Zejula review in ovarian cancer niche
GlaxoSmithKline has been working to restrengthen in cancer, particularly through a multibillion-dollar purchase of Tesaro. The main drug from the buyout, Zejula, is now...
PatientsLikeMe acquired by UnitedHealth Group
UnitedHealth Group has acquired Cambridge, Massachusetts-based patient social networking site PatientsLikeMe a few months after regulators forced its major Chinese investor iCarbonX to divest from...
Strength training could help to reduce liver fat and lower blood glucose levels
Strength training could help to lower blood glucose levels and liver fat in people with type 2 diabetes, even before weight loss...
The top 10 drug launches of 2019
Cancer is probably the most sought-after indication in the biopharma world, but it’s missing from 2019's class of top drug launches. Instead, treatments in...
From campus to consumer: Lessons on university tech transfer
University labs are one of the biggest engines of innovative healthcare technology in the country. But translating those discoveries from the campus to the...
